Merck & Co
✦ StockVane Quant Insights how this is computed
- Twelve-month momentum in the top 9% of the universe, above its 200-day average.
- Signal has read BUY for 5 months.
- Its last 5 Buy calls have averaged close to flat (+1%) three months out - no strong edge on this name specifically.
- Recent price momentum is +46.9% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Anonymous reader poll. Unscientific, not investment advice.
Performance
Key statistics
Price & volume
- Prev close
- 148.30
- Open
- 147.11
- Day range
- 147.11 - 150.00
- Avg price
- 149.25
- Volume
- 9.01M
- Turnover
- 1.34B
- Turnover ratei
- 0.37%
- Volume ratioi
- 0.81
- Amplitudei
- 1.95%
- 52-week rangei
- 79.67 - 156.00
Valuation
- P/Ei
- 20.59
- P/E (TTM)i
- 119.90
- P/Bi
- 8.82
- EPSi
- 7.28
- Book value / shi
- 17.00
- Net profit
- 17.96B
- Net assets
- 41.93B
Share structure
- Market cap
- 369.78B
- Float capi
- 369.16B
- Shares out
- 2.47B
- Float sharesi
- 2.46B
Dividend & listing
- Div yield (TTM)i
- 2.24%
- Dividend (TTM)
- 3.36
- Listing date
- 1970-01-01
3.9% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-390.69M net over the window
Short interest
- Shares short
- 28.27M
- % of floati
- 1.15%
- Days to coveri
- 2.53
- As of
- 2026-09-30
Frequently asked questions
What is the current stock price of Merck & Co (MRK)?
Merck & Co last traded at 149.88. The quote on this page refreshes every few seconds while US markets are open.
What is Merck & Co's market cap?
About 369.78B.
What is the P/E ratio of Merck & Co?
The trailing twelve-month P/E is 119.90, above its own 5-year average of 75.39 — toward the top of its historical range (88.21% percentile). See the Valuation tab for the full history.
Does Merck & Co pay a dividend?
Yes. The trailing dividend yield is 2.24%. The 2025 payout was up 5.1% from 2024. See the Dividends tab for the full payment history.
Is Merck & Co a buy according to analysts?
The consensus of 19 analysts is a Buy rating, with an average 12-month price target of 165.06, which implies 10.1% upside from the current price. This is not investment advice.
What is Merck & Co's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Merck & Co a B (Buy). Twelve-month momentum in the top 9% of the universe, above its 200-day average. Not investment advice.
Quote time 2026-10-22 00:00:00 · For reference only, not investment advice and not tailored to your situation.
the keytruda patent cliff is a few years out but the market’s already discounting it hard. pipeline needs to deliver or this stays cheap for a while, that’s the whole debate in one sentence.